BRCA1 and endometrioid adenocarcinoma: Figure 1 shows the workflow for the identification of BRCA1/2 pathogenic mutations in the current study. The Figure 1 illustrates that BRCA mutations appeared in serous and endometrioid carcinomas but not in mucinous and clear cell carcinomas.